June 14, 2019

Chemistree Announces Resignation of Non-Executive Chairman

Chemistree Technology Inc. (CSE:CHM), announces that Non-executive Chairman of the board, Justin Chorbajian has tendered his resignation.
June 11, 2019

Premium Cannabis Genetics Necessary for High-quality Cannabis Products

Cultivators looking to supply the growing cannabis concentrates market should focus on premium cannabis genetics.

June 10, 2019

Chemistree Partner, ACS, to File New Jersey Application Under New DOH Mandate

Chemistree Technology Inc. (CSE:CHM; OTC:CHMJF) (the "Company" or "Chemistree"), is pleased to announce that its partner Applied Cannabis Sciences of New Jersey ("ACS"),...
May 29, 2019

Chemesis International Inc. Receives Three Additional Cultivation Licenses & Begins Process to Increase Land Package by 10,000 Acres in Colombia

Chemistree Technology Inc. (CSE:CHM; OTC:CHMJF)(the “Company” or “Chemesis”), wholly owned subsidiary La Finca Interacviva-Arachna Med SAS (“La Finca”) announces it has...
April 29, 2019

Chemistree Acquires Ownership Stake in The Physician’s Choice CBD LLC

Chemistree Technology Inc. (CSE:CHM; OTCQB:CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the Company has entered into a...
April 18, 2019

Chemistree Provides California and Washington Operations Update

Chemistree Technology Inc. (CSE:CHM and CHM.wt) (OTCQB:CHMJF) (the "Company" or "Chemistree"), is pleased to provide shareholders with an update on...
April 15, 2019

Chemistree Announces Partnership with New Jersey Medical Retail Cannabis License Applicant

Chemistree Technology Inc. (CSE:CHM) (OTCQB:CHMJF) (the "Company" or "Chemistree"), is pleased to announce that its wholly owned U.S. subsidiary, American...